These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29427697)

  • 1. Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes.
    Venditti EM; Tan K; Chang N; Laffel L; McGinley G; Miranda N; Tryggestad JB; Walders-Abramson N; Yasuda P; Delahanty L;
    Diabetes Res Clin Pract; 2018 May; 139():24-31. PubMed ID: 29427697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to multiple medications in the TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) cohort: effect of additional medications on adherence to primary diabetes medication.
    Shah R; McKay SV; Levitt Katz LE; El Ghormli L; Anderson BJ; Casey TL; Higgins L; Izquierdo R; Wauters AD; Chang N;
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):191-198. PubMed ID: 31809265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions and experiences of taking oral medications for the treatment of Type 2 diabetes mellitus: a systematic review and meta-synthesis of qualitative studies.
    McSharry J; McGowan L; Farmer AJ; French DP
    Diabet Med; 2016 Oct; 33(10):1330-8. PubMed ID: 27150899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial determinants of adherence to oral antidiabetic medication among people with type 2 diabetes.
    Jannuzzi FF; Cornélio ME; São-João TM; Gallani MC; Godin G; Rodrigues RCM
    J Clin Nurs; 2020 Mar; 29(5-6):909-921. PubMed ID: 31856319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missed doses of oral antihyperglycemic medications in US adults with type 2 diabetes mellitus: prevalence and self-reported reasons.
    Vietri JT; Wlodarczyk CS; Lorenzo R; Rajpathak S
    Curr Med Res Opin; 2016 Sep; 32(9):1519-27. PubMed ID: 27144490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored.
    Vervloet M; van Dijk L; Santen-Reestman J; van Vlijmen B; van Wingerden P; Bouvy ML; de Bakker DH
    Int J Med Inform; 2012 Sep; 81(9):594-604. PubMed ID: 22652012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing barriers to medication adherence in underserved patients with diabetes in Texas.
    Bailey GR; Barner JC; Weems JK; Leckbee G; Solis R; Montemayor D; Pope ND
    Diabetes Educ; 2012; 38(2):271-9. PubMed ID: 22316643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes.
    Baghikar S; Benitez A; Fernandez Piñeros P; Gao Y; Baig AA
    J Immigr Minor Health; 2019 Dec; 21(6):1334-1341. PubMed ID: 30798408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya.
    Aditama L; Athiyah U; Utami W; Rahem A
    J Basic Clin Physiol Pharmacol; 2020 Jan; 30(6):. PubMed ID: 31953995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial.
    Choudhry NK; Krumme AA; Ercole PM; Girdish C; Tong AY; Khan NF; Brennan TA; Matlin OS; Shrank WH; Franklin JM
    JAMA Intern Med; 2017 May; 177(5):624-631. PubMed ID: 28241271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication adherence program: adherence challenges and interventions in type 2 diabetes.
    Odegard PS; Carpinito G; Christensen DB
    J Am Pharm Assoc (2003); 2013; 53(3):267-72. PubMed ID: 23699675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and physician factors associated with adherence to diabetes medications.
    Schoenthaler AM; Schwartz BS; Wood C; Stewart WF
    Diabetes Educ; 2012; 38(3):397-408. PubMed ID: 22446035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients with Type 2 Diabetes].
    Hayashi A; Kubo T; Okuyama K; Tokita S; Kamei M
    Yakugaku Zasshi; 2019; 139(12):1569-1581. PubMed ID: 31787647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic].
    Prázný M
    Vnitr Lek; 2014 Nov; 60(11):999-1006. PubMed ID: 25600048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient perspectives on once-weekly medications for diabetes.
    Polonsky WH; Fisher L; Hessler D; Bruhn D; Best JH
    Diabetes Obes Metab; 2011 Feb; 13(2):144-9. PubMed ID: 21199266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of adherence to diabetes medications: the role of disease and medication beliefs.
    Mann DM; Ponieman D; Leventhal H; Halm EA
    J Behav Med; 2009 Jun; 32(3):278-84. PubMed ID: 19184390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China.
    Hu Y; Zhong XN; Peng B; Zhang Y; Liang H; Dai JH; Zhang JY; Huang AL
    BMC Infect Dis; 2018 Nov; 18(1):575. PubMed ID: 30442106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving adherence and reducing medication discrepancies in patients with diabetes.
    Grant RW; Devita NG; Singer DE; Meigs JB
    Ann Pharmacother; 2003; 37(7-8):962-9. PubMed ID: 12841801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with reluctance to initiate or continue oral antihyperglycemic agent (OAHA) treatments in type 2 diabetes mellitus patients in Japan: An observational patient-reported study.
    Kubo T; Okuyama K; Zhao X; Singh SS; Tokita S
    Diabetes Metab Syndr; 2019; 13(2):1201-1207. PubMed ID: 31336465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.